glp 1 anti obesity Anti-obesity drugs are closing the gap between dieting and bariatric surgery | Diet and Nutrition | Prevention GLP-1 Agonist to Treat Obesity

People with macular degeneration experience a gradual loss of vision - especially in the central visual field

Recently, the STEP-HFpEF trial enrolled 529 non-diabetic patients with HFpEF and obesity, who were randomly assigned to receive either once-weekly semaglutide (2.4 mg) or placebo for 52 weeks

Inborn errors of metabolism account for only 5% of all pediatric cardiomyopathy, and 15% of those are due to known causes, but they are of particular interest to clinicians because many have disease-specific treatments.2) Identification of underlying causes of cardiomyopathy with subsequent disease-specific treatments may lead to improved outcomes

Status of GLP-1RA drug in developing MASLD indication Generally, targeted drugs include single GLP-1R agonists and co-agonists, as well as combination formulations, innovative oral peptide preparations, and non-peptide small molecule agonists

A randomized controlled trial published in the journal Nutrients found that women who were overweight or obese and took 3 g of CLA per day had significant reductions in total body fat after 12 weeks

The Benefits of Dihexa Nov 252022 Dihexa is known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met